Immunization, Passive

"Immunization, Passive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER).

Descriptor ID	D007116
MeSH Number(s)	E02.095.465.425.400.330 E05.478.550.520
Concept/Terms	Immunization, Passive Immunization, Passive Immunizations, Passive Passive Immunization Passive Immunizations Passive Antibody Transfer Passive Antibody Transfer Antibody Transfer, Passive Antibody Transfers, Passive Passive Antibody Transfers Transfer, Passive Antibody Transfers, Passive Antibody Passive Transfer of Immunity Serotherapy Serotherapy Serotherapies Immunotherapy, Passive Immunotherapy, Passive Passive Immunotherapy Immunotherapies, Passive Passive Immunotherapies Immunoglobulin Therapy Immunoglobulin Therapy Therapy, Immunoglobulin Immunoglobulin Therapies Therapies, Immunoglobulin Normal Serum Globulin Therapy Normal Serum Globulin Therapy

Below are MeSH descriptors whose meaning is more general than "Immunization, Passive".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Biological Therapy [E02.095]
Immunomodulation [E02.095.465]
Immunotherapy [E02.095.465.425]
Immunization [E02.095.465.425.400]
Immunization, Passive [E02.095.465.425.400.330]
Investigative Techniques [E05]
Immunologic Techniques [E05.478]
Immunization [E05.478.550]
Immunization, Passive [E05.478.550.520]

Below are MeSH descriptors whose meaning is related to "Immunization, Passive".

Below are MeSH descriptors whose meaning is more specific than "Immunization, Passive".

Immunization, Passive
Adoptive Transfer

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Immunization, Passive" by people in this website by year, and whether "Immunization, Passive" was a major or minor topic of these publications.

Bar chart showing 9 publications over 8 distinct years, with a maximum of 2 publications in 1996

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
2004	0	1	1
2013	0	1	1
2015	0	1	1
2016	0	1	1
2019	1	0	1
2021	1	0	1
2023	0	1	1

Below are the most recent publications written about "Immunization, Passive" by people in Profiles.

Bajoria S, Antunez LR, Kumru OS, Klempner M, Wang Y, Cavacini LA, Joshi SB, Volkin DB. Formulation Studies to Develop Low-Cost, Orally-Delivered Secretory IgA Monoclonal Antibodies for Passive Immunization Against Enterotoxigenic Escherichia coli. J Pharm Sci. 2023 07; 112(7):1832-1844.

View in: PubMed
Parzych EM, Gulati S, Zheng B, Bah MA, Elliott STC, Chu JD, Nowak N, Reed GW, Beurskens FJ, Schuurman J, Rice PA, Weiner DB, Ram S. Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection. mBio. 2021 03 16; 12(2).

View in: PubMed
Sun S, Su W, Lin CQ, Li X, Yan H, Tian B, Lin H. COVID-19: the novel coronavirus disease and its manifestations and management in ophthalmology. Discov Med. 2020 May-Jun; 29(158):145-157.

View in: PubMed
Cross RW, Hastie KM, Mire CE, Robinson JE, Geisbert TW, Branco LM, Ollmann Saphire E, Garry RF. Antibody therapy for Lassa fever. Curr Opin Virol. 2019 08; 37:97-104.

View in: PubMed
Hu Y, Kumru OS, Xiong J, Antunez LR, Hickey J, Wang Y, Cavacini L, Klempner M, Joshi SB, Volkin DB. Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration. J Pharm Sci. 2020 01; 109(1):407-421.

View in: PubMed
Wang Y, Kern A, Boatright NK, Schiller ZA, Sadowski A, Ejemel M, Souders CA, Reimann KA, Hu L, Thomas WD, Klempner MS. Pre-exposure Prophylaxis With OspA-Specific Human Monoclonal Antibodies Protects Mice Against Tick Transmission of Lyme Disease Spirochetes. J Infect Dis. 2016 07 15; 214(2):205-11.

View in: PubMed
Fouda GG, Eudailey J, Kunz EL, Amos JD, Liebl BE, Himes J, Boakye-Agyeman F, Beck K, Michaels AJ, Cohen-Wolkowiez M, Haynes BF, Reimann KA, Permar SR. Systemic administration of an HIV-1 broadly neutralizing dimeric IgA yields mucosal secretory IgA and virus neutralization. Mucosal Immunol. 2017 01; 10(1):228-237.

View in: PubMed
Bornholdt ZA, Turner HL, Murin CD, Li W, Sok D, Souders CA, Piper AE, Goff A, Shamblin JD, Wollen SE, Sprague TR, Fusco ML, Pommert KB, Cavacini LA, Smith HL, Klempner M, Reimann KA, Krauland E, Gerngross TU, Wittrup KD, Saphire EO, Burton DR, Glass PJ, Ward AB, Walker LM. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Science. 2016 Mar 04; 351(6277):1078-83.

View in: PubMed
Gulati S, Mu X, Zheng B, Reed GW, Ram S, Rice PA. Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model. J Infect Dis. 2015 Jul 15; 212(2):311-5.

View in: PubMed
Gulati S, Zheng B, Reed GW, Su X, Cox AD, St Michael F, Stupak J, Lewis LA, Ram S, Rice PA. Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection. PLoS Pathog. 2013; 9(8):e1003559.

View in: PubMed

People

Explore

Similar Concepts

Top Journals